Imagine a world without safe medicine. It is a scary thought. The Medicines and Healthcare Products Regulatory Agency ensures our medicines are safe. It also makes sure medical devices work.
The Medicines and Healthcare Products Regulatory Agency or MHRA stands here as a protector of public health. MHRA is an executive agency sponsored by the Department of Health and Social Care. It regulates medicines, medical devices and blood components for transfusion in the UK.
Formed in 2003, the Medicines and Healthcare Products Regulatory Agency merged the Medicines Control Agency and the Medical Devices Agency. In 2013, the National Institute for Biological Standards and Control joined and was rebranded. The MHRA identity became the regulatory center’s name.
The Medicines and Healthcare Products Regulatory Agency puts patients first. It rigorously uses science and data. This informs decisions and enables medical innovation. The goal is safe and effective healthcare products.
What does the Medicines and Healthcare Products Regulatory Agency do? It ensures medicines meet safety and quality standards. It secures the medicine supply chain. The Medicines and Healthcare Products Regulatory Agency promotes international standardization. It educates the public about medicine risks and benefits. It enables beneficial innovation. The MHRA collaborates with partners for early access to safe medicines.
The Medicines and Healthcare Products Regulatory Agency operates within a statutory framework set by the government. These policies define its role. They give it power to improve public health.
The Medicines and Healthcare Products Regulatory Agency regulates medicines and vaccines. It also oversees medical devices and blood components. The MHRA even regulates e-cigarettes. It also keeps an eye on traditional herbal and homeopathic remedies.
The Medicines and Healthcare Products Regulatory Agency is governed by a unitary board of directors. It has executive and non-executive directors. A non-executive chairperson supports them. The board advises on strategic direction. It ensures targets are met. The chief executive and executive committee make regulatory decisions.
Several independent advisory bodies support the Medicines and Healthcare Products Regulatory Agency. They include the Advisory Board on the Registration of Homeopathic Products. Also the Blood Consultative Committee and the British Pharmacopoeia. The Commission on Human Medicines is another. They provide expert advice on various aspects of regulation.
MHRA plays a vital role in post-marketing surveillance. The Yellow Card Scheme reports and monitors adverse drug reactions. It also does the same for medical device incidents. The Medicines and Healthcare Products Regulatory Agency assesses medicinal products for sale in the UK. It oversees notified bodies that ensure device manufacturers comply with regulations.
The Medicines and Healthcare Products Regulatory Agency operates a quality surveillance system. It samples and tests medicines. It addresses quality defects. It monitors unlicensed products’ safety. The MHRA investigates internet sales and counterfeiting. It prosecutes when necessary.
The Medicines and Healthcare Products Regulatory Agency regulates clinical trials. It ensures compliance with statutory obligations. The MHRA promotes the safe use of medicines and devices. It manages the Clinical Practice Research Datalink and the British Pharmacopoeia.
During COVID-19, the Medicines and Healthcare Products Regulatory Agency approved vaccines quickly. It was the first global regulator to approve the Pfizer-BioNTech vaccine. The MHRA also approved the Oxford-AstraZeneca and Moderna vaccines.
The Medicines and Healthcare Products Regulatory Agency also ensures tests are reliable. It raised concerns about lateral flow tests in schools. The MHRA also considers reclassifying cough syrups containing codeine. This is in response to rising abuse cases.
The Medicines and Healthcare Products Regulatory Agency stands as a guardian. It protects the public through diligent regulation. It embraces innovation. The agency ensures access to safe and effective healthcare products. The Medicines and Healthcare Products Regulatory Agency remains dedicated to public health.